The influence of formulation components on the aerosolisation properties of spray-dried powders
- 13 October 2005
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 110 (1), 130-140
- https://doi.org/10.1016/j.jconrel.2005.09.004
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- The use of absorption enhancers to enhance the dispersibility of spray‐dried powders for pulmonary gene therapyThe Journal of Gene Medicine, 2005
- The use of amino acids to enhance the aerosolisation of spray‐dried powders for pulmonary gene therapyThe Journal of Gene Medicine, 2004
- Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturingEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Are all estrogens the same?Maturitas, 2004
- Enhanced Dispersibility and Deposition of Spray-dried Powders for Pulmonary Gene TherapyJournal of Drug Targeting, 2003
- Vaginal ring delivery of hormone replacement therapy – a reviewExpert Opinion on Pharmacotherapy, 2003
- Preparation of dry powder dispersions for non‐viral gene delivery by freeze‐drying and spray‐dryingThe Journal of Gene Medicine, 2002
- Aerodiol® versus the transdermal route: perspectives for patient preferenceMaturitas, 2001
- Inhalation of Estradiol for Sustained Systemic DeliveryJournal of Aerosol Medicine, 1999
- Preparation of peptide and protein powders for inhalationAdvanced Drug Delivery Reviews, 1997